|
|
To enact sections 3701.781, 3701.782, 3701.783, | 1 |
3701.784, 3701.785, and 3701.786 of the Revised | 2 |
Code to create the Lupus Education and Awareness | 3 |
Program. | 4 |
Section 1. That sections 3701.781, 3701.782, 3701.783, | 5 |
3701.784, 3701.785, and 3701.786 of the Revised Code be enacted to | 6 |
read as follows: | 7 |
Sec. 3701.781. (A) The commission on minority health shall | 8 |
establish, promote, and maintain a lupus education and awareness | 9 |
program with an emphasis on minority populations and at-risk | 10 |
communities to raise public awareness, educate consumers, and | 11 |
educate and train health professionals, human services providers, | 12 |
and other audiences. | 13 |
(B) The commission, in creating and implementing the program, | 14 |
shall do all of the following: | 15 |
(1) Provide sufficient staff and appropriate training to | 16 |
implement the program; | 17 |
(2) Establish a grant program to support nonprofit voluntary | 18 |
health organizations with expertise in lupus to increase public | 19 |
awareness and enhance health professional education and | 20 |
understanding of the symptoms and consequences of lupus and the | 21 |
populations most at risk; | 22 |
(3) Establish an intergovernmental council and advisory panel | 23 |
to oversee the implementation of the program; | 24 |
(4) Identify the appropriate entities to carry out the | 25 |
program; | 26 |
(5) Base the program on the most current scientific | 27 |
information and findings; | 28 |
(6) Work with government entities, community and business | 29 |
leaders, community organizations, health and human services | 30 |
providers, and national, state, and local lupus organizations, | 31 |
such as the lupus foundation of America, inc., to coordinate | 32 |
efforts to maximize state resources in the areas of lupus | 33 |
education and awareness; | 34 |
(7) Identify and use other successful lupus education and | 35 |
awareness programs and procure related materials and services from | 36 |
organizations with appropriate expertise and knowledge of lupus. | 37 |
(C) The commission may accept gifts, grants, and donations | 38 |
from the federal government, foundations, organizations, medical | 39 |
schools, and other entities for fulfilling the obligations of the | 40 |
program. | 41 |
(D) The commission shall seek any federal waiver that may be | 42 |
necessary to maximize funds from the federal government to | 43 |
implement the program. | 44 |
Sec. 3701.782. (A)(1) The commission on minority health shall | 45 |
conduct a needs assessment to identify all of the following: | 46 |
(a) The level of statewide health professional and public | 47 |
awareness about lupus; | 48 |
(b) The existence of lupus education, awareness, and | 49 |
treatment programs and related technical assistance available in | 50 |
the state and nationwide; | 51 |
(c) The lupus-related educational and support service needs | 52 |
of health care providers in the state, including physicians, | 53 |
nurses, health plans, and other health professionals and health | 54 |
care entities; | 55 |
(d) The needs of people with lupus, their families, and | 56 |
caregivers, including health care providers, physicians, nurses, | 57 |
health care plans, and other health professionals and health care | 58 |
entities; | 59 |
(e) The services available to individuals with lupus, | 60 |
including the existence and availability of lupus treatment and | 61 |
specialty care, lupus support groups, and other related care and | 62 |
management services. | 63 |
(2) Based on the needs assessment, the commission shall | 64 |
develop and maintain a directory of lupus-related services and | 65 |
health care providers with specialization in services to diagnose | 66 |
and treat lupus. The commission shall disseminate the directory to | 67 |
all stakeholders, including individuals with lupus, families, | 68 |
representatives from voluntary organizations, health | 69 |
professionals, health plans, and state and local health agencies. | 70 |
(B) The commission shall undertake activities to raise public | 71 |
awareness about the symptoms of lupus, personal risk factors, and | 72 |
options for diagnosing and treating the disease with a particular | 73 |
focus on populations at elevated risk for lupus, including women | 74 |
and communities of color. Such activities shall include but not be | 75 |
limited to the following: | 76 |
(1) Implementing a statewide campaign to educate the general | 77 |
public about lupus by utilizing print, radio, and television | 78 |
public service announcements, advertisements, posters, and other | 79 |
materials; | 80 |
(2) Disseminating health information and conducting | 81 |
individual risk assessments at public events, such as health fairs | 82 |
and community forums sponsored by the Ohio department of health; | 83 |
(3) Distributing information through local health | 84 |
departments; schools; area agencies on aging; employer wellness | 85 |
programs; physicians and other health professionals; hospitals and | 86 |
health plans; women's, health, nonprofit, and community-based | 87 |
organizations; and regional offices of the Ohio department of | 88 |
health. | 89 |
Sec. 3701.783. (A) The commission on minority health shall | 90 |
establish a program to award grants to educate and train | 91 |
physicians, health professionals, and other service providers on | 92 |
the most current, accurate scientific and medical information on | 93 |
lupus diagnosis, treatment, and therapeutic decision-making, | 94 |
including medical best practices for detecting and treating the | 95 |
disease in special populations, risks and benefits of medications, | 96 |
and research advances. In awarding grants, the commission shall | 97 |
allocate the total amount available for the grants in amounts that | 98 |
are proportionate to the populations of the areas served by the | 99 |
Ohio chapters of the lupus foundation of America, inc. | 100 |
To be eligible for a grant, an applicant must be affiliated | 101 |
with the foundation. | 102 |
(B) Each grant recipient shall do all of the following: | 103 |
(1) Develop health professional educational materials that | 104 |
identify the latest scientific and medical information and | 105 |
clinical applications; | 106 |
(2) Work to increase knowledge among physicians, nurses, and | 107 |
health and human services professionals about the importance of | 108 |
lupus diagnosis, treatment, and rehabilitation; | 109 |
(3) Use available curricula for training of health and human | 110 |
services providers and community leaders on lupus detection and | 111 |
treatment; | 112 |
(4) Support continuing medical education programs in all | 113 |
geographical areas in the state presented by the leading state | 114 |
academic institutions by providing the most current information; | 115 |
(5) Provide workshops and seminars for in-depth professional | 116 |
development in the field of care and management of lupus patients | 117 |
to bring the latest information on clinical advances to care | 118 |
providers; | 119 |
(6) Conduct statewide conferences on lupus at appropriate | 120 |
intervals; | 121 |
(7) Prepare an annual report that describes the recipient's | 122 |
use of the grant and submit a copy of the report to the | 123 |
commission. | 124 |
Sec. 3701.784. (A) In establishing the intergovernmental | 125 |
council as required by division (B)(3) of section 3701.781 of the | 126 |
Revised Code, the commission on minority health shall seek to | 127 |
ensure coordination of lupus education and awareness efforts and | 128 |
efforts to address health conditions disproportionately affecting | 129 |
women and people of color. The chairperson of the commission shall | 130 |
serve as the council's chairperson. The council shall include | 131 |
representatives from appropriate state departments and agencies, | 132 |
including entities with responsibility for health disparities, | 133 |
medicaid, public health programs, education, public welfare, and | 134 |
women's health programs. | 135 |
(B) The council shall do all of the following: | 136 |
(1) Provide oversight to the lupus education and awareness | 137 |
program, as well as other lupus programs conducted by the | 138 |
commission; | 139 |
(2) Develop and issue grant applications and policies and | 140 |
procedures for programs aimed at health professionals and the | 141 |
public; | 142 |
(3) Establish a mechanism for sharing information on lupus | 143 |
among all officials and employees involved in carrying out | 144 |
lupus-related programs; | 145 |
(4) Assist the commission and other offices in developing and | 146 |
coordinating plans for education and health promotion on lupus and | 147 |
ensure that issues related to lupus are integrated into other | 148 |
statewide plans; | 149 |
(5) Prepare an annual report that describes educational | 150 |
initiatives on lupus sponsored by the state and make | 151 |
recommendations for new educational initiatives on lupus. The | 152 |
report shall be transmitted to the general assembly and be made | 153 |
available to the public. | 154 |
Sec. 3701.785. (A) In establishing the advisory panel as | 155 |
required by division (B)(3) of section 3701.781 of the Revised | 156 |
Code, the commission on minority health shall coordinate the panel | 157 |
to provide input and counsel regarding the lupus education and | 158 |
awareness program. | 159 |
(B)(1) Individuals and organizations may submit nominations | 160 |
to the commission to be appointed. Each panel member shall have | 161 |
familiarity with lupus and issues that surround lupus. | 162 |
(2) The panel shall be comprised of the following members to | 163 |
be appointed by the commission: | 164 |
(a) At least three individuals with lupus, at least one of | 165 |
whom is a member of a minority group; | 166 |
(b) Not more than two representatives from the commission; | 167 |
(c) At least five individuals from lupus nonprofit health | 168 |
organizations, with preference given to individuals from the lupus | 169 |
foundation of America, inc.; | 170 |
(d) At least five scientists or clinicians with experience in | 171 |
lupus who participate in various fields of scientific endeavor, | 172 |
including the fields of biomedical research, social, | 173 |
translational, behavioral and epidemiological research, and public | 174 |
health. | 175 |
(3) The commission shall select from among the panel members | 176 |
one member to serve as chairperson of the panel. | 177 |
Members of the panel shall serve terms of two years each. | 178 |
Members may be named to serve a total of two terms and terms may | 179 |
be consecutive. | 180 |
A majority of the members of the panel constitutes a quorum. | 181 |
A majority vote of a quorum is required for any official action of | 182 |
the panel. | 183 |
The panel shall meet at the call of the panel chairperson, | 184 |
but not fewer than four times per year. | 185 |
All members shall serve without compensation, but may be | 186 |
reimbursed for actual, necessary expenses incurred in the | 187 |
performance of their duties. | 188 |
(4) The panel shall be responsible for advising the | 189 |
commission and the intergovernmental council with respect to the | 190 |
implementation of the lupus education and awareness program. The | 191 |
commission shall consult with the advisory panel on a regular | 192 |
basis. | 193 |
Sec. 3701.786. There is hereby created in the state treasury | 194 |
the lupus education and awareness program fund. All moneys | 195 |
accepted under division (C) of section 3701.781 of the Revised | 196 |
Code shall be credited to the fund. The commission shall use the | 197 |
fund to administer the lupus education and awareness program under | 198 |
section 3701.781 of the Revised Code. | 199 |
Section 2. The General Assembly hereby finds the following: | 200 |
(A) Lupus is a serious, complex, debilitating autoimmune | 201 |
disease that can cause inflammation and tissue damage to virtually | 202 |
any organ system in the body, including the skin, joints, other | 203 |
connective tissue, blood and blood vessels, heart, lungs, kidney, | 204 |
and brain. | 205 |
(B) The Lupus Foundation of America, Inc., estimates that | 206 |
approximately 1.5 to 2 million Americans live with lupus; lupus | 207 |
affects women nine times more often than men and 80 per cent of | 208 |
newly diagnosed cases of lupus develop among women of childbearing | 209 |
age. | 210 |
(C) Lupus disproportionately affects women of color; it is | 211 |
two to three times more common among African Americans, Hispanics, | 212 |
Asians, and Native Americans and is generally more prevalent in | 213 |
minority populations. According to the Centers for Disease Control | 214 |
and Prevention, the rate of lupus mortality has increased since | 215 |
the late 1970's and is higher among older African-American women. | 216 |
(D) No new drugs have been approved by the U.S. Food and Drug | 217 |
Administration specifically for lupus in nearly 40 years and while | 218 |
current treatments for the disease can be effective, they can | 219 |
cause damaging side effects. | 220 |
(E) The pain and fatigue associated with lupus can threaten | 221 |
the ability to live independently, maintain employment, and lead a | 222 |
normal life. One in five individuals with lupus is disabled by the | 223 |
disease, and consequently receives support from government | 224 |
programs, including Medicare, Medicaid, Social Security | 225 |
Disability, and Social Security Supplemental Income. | 226 |
(F) The estimated average annual cost of medical treatment | 227 |
for an individual with lupus is between $10,000 and $30,000; for | 228 |
individuals who have the most serious form of lupus, medical costs | 229 |
can greatly exceed this amount, causing a significant economic, | 230 |
emotional, and social burden to the entire family and society. | 231 |
(G) More than half of individuals with lupus suffer four or | 232 |
more years and visit three or more physicians before obtaining a | 233 |
diagnosis of lupus; early diagnosis of and treatment for lupus can | 234 |
prevent or reduce serious organ damage, disability, and death. | 235 |
(H) Despite the magnitude of lupus and its impact on | 236 |
individuals and families, health professional and public | 237 |
understanding of lupus remains low; only one in five Americans can | 238 |
provide basic information about lupus, and awareness of lupus is | 239 |
lowest among adults 18 to 34 years of age - the age group most | 240 |
likely to develop lupus. | 241 |
(I) Lupus is a significant national health issue that | 242 |
deserves a comprehensive and coordinated response by state and | 243 |
federal governments with involvement of the health care provider, | 244 |
patient, and public health communities. | 245 |
Section 3. The purpose of this act is to create a | 246 |
multi-pronged, statewide program to promote public and health | 247 |
professional awareness and increase knowledge concerning the | 248 |
causes and consequences of lupus, the importance of early | 249 |
diagnosis and appropriate management, and effective treatment and | 250 |
management strategies by all of the following: | 251 |
(A) Conducting educational and training programs for health | 252 |
professionals on lupus diagnosis and management; | 253 |
(B) Developing and disseminating educational materials and | 254 |
information to patients and health professionals on lupus research | 255 |
results and health care services available; | 256 |
(C) Designing and implementing a statewide public education | 257 |
campaign aimed at heightening public awareness of lupus; | 258 |
(D) Leveraging educational and training resources and | 259 |
services previously developed by organizations with appropriate | 260 |
expertise and knowledge of lupus. | 261 |